Effects of carbon ion beam on putative colon cancer stem cells and its comparison with x-rays

Cancer Research

Volumn 71, Issue 10, 2011, Pages 3676-3687

  Cui, Xing ^a   Oonishi, Kazuhiko ^b,c   Tsujii, Hirohiko ^b   Yasuda, Takeshi ^a   Matsumoto, Yoshitaka ^a   Furusawa, Yoshiya ^a   Akashi, Makoto ^c   Kamada, Tadashi ^b   Okayasu, Ryuichi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; HERMES ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL SURVIVAL; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE ACTIVATED CELL SORTING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; ION THERAPY; MALE; MOUSE; NONHUMAN; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SPHEROID CELL; TARGET CELL; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARBON; CELL LINE, TUMOR; CELL SEPARATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HEAVY IONS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; PEPTIDES; RADIOTHERAPY; X-RAYS;

EID: 79956095898     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2926     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, et al. The benefit of leucovorin modulated 5-fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from the National Surgery and Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11:1879-87. (Pubitemid 23304611)
3. Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:201-10. (Pubitemid 29186209)
4. Suzuki M, Kase Y, Yamaguchi H, Kanai T, Ando K. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbonion beams. Int J Radiat Oncol Biol Phys 2000;48:241-50. (Pubitemid 30488236)
5. Griffin TW. Particle-beam radiation therapy. In:Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology. 2nd ed. Philadelphia, PA: J.B. Lippincott Co.; 1992. p. 368-87.
6. Okayasu R, Okada M, Okabe A, Noguchi M, Takakura K, Takahashi S, et al. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous endjoining pathway. Radiat Res 2006;165:59-67. (Pubitemid 43023325)
7. Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002;20:4466-71. (Pubitemid 35339406)
8. Tsujii H, Mizoe JE, Kamada T, Baba M, Kato S, Kato H, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73Suppl 2:S41-9.
9. Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, et al. Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 2007;48 Suppl A:A1-13.
10. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953-64. (Pubitemid 350002861)
11. Zou GM. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 2008;217:598-604.
12. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M, et al. CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 2008;8:784-804.
13. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432: 396-401. (Pubitemid 39551674)
14. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12 (Pubitemid 28007217)
15. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT, et al. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008;68:9703-11.
16. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10. (Pubitemid 46067310)
17. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-5. (Pubitemid 46067311)
18. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008;105:13427-32.
19. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60. (Pubitemid 44949604)
20. Hambardzumyan D, Squatrito M, Holland EC. Radiation resistance and stem-like cells in brain tumors. Cancer Cell 2006;10:454-6. (Pubitemid 44854752)
21. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007;67:8980-4. (Pubitemid 47535877)
22. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008;8:545-54. (Pubitemid 351881850)
23. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006;98:1755-7. (Pubitemid 46017927)
24. Dingli D, Michor F. Successful therapy must eradicate cancer stem cells. Stem Cells 2006;24:2603-10. (Pubitemid 46052998)
25. Ischenko I, Seeliger H, Schaffer M, Jauch KW, Bruns CJ. Cancer stem cells: how can we target them? Curr Med Chem 2008;15:3171-84.
26. Cui X, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K, Hirano S, et al. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum Pathol 2006;37:298-311. (Pubitemid 43277518)
27. Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci 2006;91:372-81. (Pubitemid 43827290)
28. Matsui Y, Asano T, Kenmochi T, Iwakawa M, Imai T, Ochiai T. Effects of carbon-ion beams on human pancreatic cancer cell lines that differ in genetic status. Am J Clin Oncol 2004;27:24-8. (Pubitemid 38176287)
29. Takahashi Y, Teshima T, Kawaguchi N, Hamada Y, Mori S, Madachi A, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res 2003;63:4253-7. (Pubitemid 36917954)
30. Koike S, Ando K, Oohira C, Fukawa T, Lee R, Takai N, et al. Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma. J Radiat Res 2002;43:247-55. (Pubitemid 135691179)
31. Peschke P, Karger CP, Scholz M, Debus J, Huber PE. Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat. Int J Radiat Oncol Biol Phys 2011;79:239-46.
32. Beck-Bornholdt HP, Würschmidt F, Vogler H. Net growth delay: a novel parameter derived from tumor growth curves. Int J Radiat Oncol Biol Phys 1987;13:773-7. (Pubitemid 17071656)
33. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumour radioresistance. J Natl Cancer Inst 2006;98:1755-7. (Pubitemid 46017927)
34. Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008;27:1749-58. (Pubitemid 351380265)
35. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008;14:8205-12.
36. Horst D, Kriegl L, Engel J, Kirchner T, Jung A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008;99:1285-9.
37. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-68.
38. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stemcells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-44. (Pubitemid 44623625)
39. Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyamoto T, et al. Working Group for Bone, Soft Tissue Sarcomas. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 2004;10:5741-6.
40. Mobaraki A, Ohno T, Yamada S, Sakurai H, Nakano T. Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer. Cancer Sci 2010;101:1834-9.